Literature DB >> 17902144

Evolution of CFTR protein distribution in lung tissue from normal and CF human fetuses.

Pascale Marcorelles1, Tristan Montier, Danièle Gillet, Nicole Lagarde, Claude Ferec.   

Abstract

In order to determine whether or not CFTR protein distribution differs between the airways of fetuses with Cystic Fibrosis (CF) from the airways of normal fetuses we studied the distribution pattern of the CFTR protein in lung. Cases of normal and CF human fetuses as well as cases of normal neonates were examinated. Our aim was to establish whether CFTR expression during pregnancy could be correlated with the maturation of the airways, and to compare normal and CF samples. We hypothesized that any difference between normal and CF fetal lung in CFTR protein expression could be related to a functional change appearing in early development even if no morphological differences could be detected at the light microscopic level. The distribution of CFTR protein progressively increased from 10 weeks of gestation (WG) to mid-gestation, but thereafter decreased until term. The CFTR protein was first detected in the cytoplasm of undifferentiated epithelial cells. Before mid-gestation, the immunostaining was strongly positive in bronchi, in sub-mucosal glands, and in lung parenchyma. Then, it became localized to the apical zone of the epithelial cells. This pattern correlated with differentiation during the second half of gestation. The main difference observed between normal and CF fetuses was a 3-week delay in detectability of the CFTR protein expression in the latter until 15 weeks of gestation. These results support the hypothesis of an early functional change. Abnormal fetal lung CFTR protein regulation could give rise to a predisposition to the post-natal inflammatory changes of the airways that characterize CF disease. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17902144     DOI: 10.1002/ppul.20690

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.

Authors:  Mairi J Hunter; Kate J Treharne; Alexandra K Winter; Diane M Cassidy; Stephen Land; Anil Mehta
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

2.  Accumulation of metals in GOLD4 COPD lungs is associated with decreased CFTR levels.

Authors:  Fatemat Hassan; Xiaohua Xu; Gerard Nuovo; David W Killilea; Jean Tyrrell; Chong Da Tan; Robert Tarran; Philip Diaz; Junbae Jee; Daren Knoell; Prosper N Boyaka; Estelle Cormet-Boyaka
Journal:  Respir Res       Date:  2014-06-23

3.  The extracellular calcium-sensing receptor regulates human fetal lung development via CFTR.

Authors:  Sarah C Brennan; William J Wilkinson; Hsiu-Er Tseng; Brenda Finney; Bethan Monk; Holly Dibble; Samantha Quilliam; David Warburton; Luis J Galietta; Paul J Kemp; Daniela Riccardi
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

4.  Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs.

Authors:  David K Meyerholz; David A Stoltz; Nick D Gansemer; Sarah E Ernst; Daniel P Cook; Matthew D Strub; Erica N LeClair; Carrie K Barker; Ryan J Adam; Mariah R Leidinger; Katherine N Gibson-Corley; Philip H Karp; Michael J Welsh; Paul B McCray
Journal:  Lab Invest       Date:  2018-02-21       Impact factor: 5.662

Review 5.  What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?

Authors:  Margarida D Amaral; Margarida C Quaresma; Ines Pankonien
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

Review 6.  Cystic fibrosis as a bowel cancer syndrome and the potential role of CK2.

Authors:  Anil Mehta
Journal:  Mol Cell Biochem       Date:  2008-07-05       Impact factor: 3.396

7.  CFTR and Wnt/beta-catenin signaling in lung development.

Authors:  J Craig Cohen; Janet E Larson; Erin Killeen; Damon Love; Ken-Ichi Takemaru
Journal:  BMC Dev Biol       Date:  2008-07-06       Impact factor: 1.978

Review 8.  Emerging microRNA Therapeutic Approaches for Cystic Fibrosis.

Authors:  Pauline Bardin; Florence Sonneville; Harriet Corvol; Olivier Tabary
Journal:  Front Pharmacol       Date:  2018-10-08       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.